

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.36371784 |
| 2 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.96647660 |
| 3 | purine nucleobase biosynthetic process (GO:0009113) | 4.69662882 |
| 4 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.68188317 |
| 5 | nucleobase biosynthetic process (GO:0046112) | 4.63671461 |
| 6 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.60945353 |
| 7 | formation of translation preinitiation complex (GO:0001731) | 4.57509839 |
| 8 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.56862177 |
| 9 | * negative regulation of ligase activity (GO:0051352) | 4.52223881 |
| 10 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.52223881 |
| 11 | DNA deamination (GO:0045006) | 4.43129234 |
| 12 | cullin deneddylation (GO:0010388) | 4.42479726 |
| 13 | * regulation of cellular amino acid metabolic process (GO:0006521) | 4.39709915 |
| 14 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.38016892 |
| 15 | maturation of SSU-rRNA (GO:0030490) | 4.34832017 |
| 16 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.26713201 |
| 17 | protein deneddylation (GO:0000338) | 4.25508611 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.25058621 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.22551651 |
| 20 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.19016480 |
| 21 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.19016480 |
| 22 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.17923652 |
| 23 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.17923652 |
| 24 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.17923652 |
| 25 | DNA strand elongation (GO:0022616) | 4.17812638 |
| 26 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.15776413 |
| 27 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.12129027 |
| 28 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.10229192 |
| 29 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.10229192 |
| 30 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.06501835 |
| 31 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.05850621 |
| 32 | DNA replication initiation (GO:0006270) | 4.04443438 |
| 33 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.01216202 |
| 34 | termination of RNA polymerase III transcription (GO:0006386) | 4.01216202 |
| 35 | 7-methylguanosine mRNA capping (GO:0006370) | 3.96311316 |
| 36 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.93466015 |
| 37 | spliceosomal snRNP assembly (GO:0000387) | 3.92447198 |
| 38 | RNA capping (GO:0036260) | 3.87110323 |
| 39 | 7-methylguanosine RNA capping (GO:0009452) | 3.87110323 |
| 40 | ribosome biogenesis (GO:0042254) | 3.86885477 |
| 41 | * positive regulation of ligase activity (GO:0051351) | 3.85864672 |
| 42 | * negative regulation of protein ubiquitination (GO:0031397) | 3.84602102 |
| 43 | rRNA modification (GO:0000154) | 3.80858718 |
| 44 | ribosomal large subunit biogenesis (GO:0042273) | 3.80610325 |
| 45 | ATP synthesis coupled proton transport (GO:0015986) | 3.76730280 |
| 46 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.76730280 |
| 47 | establishment of viral latency (GO:0019043) | 3.76676863 |
| 48 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.75767894 |
| 49 | ribosome assembly (GO:0042255) | 3.75511526 |
| 50 | telomere maintenance via recombination (GO:0000722) | 3.72105071 |
| 51 | chaperone-mediated protein transport (GO:0072321) | 3.68461934 |
| 52 | regulation of translational termination (GO:0006449) | 3.67765418 |
| 53 | DNA replication checkpoint (GO:0000076) | 3.67396097 |
| 54 | protein maturation by protein folding (GO:0022417) | 3.65993870 |
| 55 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.64907162 |
| 56 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.64581522 |
| 57 | ribosomal small subunit biogenesis (GO:0042274) | 3.63064474 |
| 58 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.61382910 |
| 59 | amino acid salvage (GO:0043102) | 3.60440333 |
| 60 | L-methionine salvage (GO:0071267) | 3.60440333 |
| 61 | L-methionine biosynthetic process (GO:0071265) | 3.60440333 |
| 62 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.55938787 |
| 63 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.55405283 |
| 64 | CENP-A containing nucleosome assembly (GO:0034080) | 3.52631328 |
| 65 | * cell cycle G1/S phase transition (GO:0044843) | 3.52571317 |
| 66 | * G1/S transition of mitotic cell cycle (GO:0000082) | 3.52571317 |
| 67 | pseudouridine synthesis (GO:0001522) | 3.50776653 |
| 68 | rRNA processing (GO:0006364) | 3.50656042 |
| 69 | viral mRNA export from host cell nucleus (GO:0046784) | 3.49954660 |
| 70 | * regulation of ligase activity (GO:0051340) | 3.46038978 |
| 71 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.45021846 |
| 72 | IMP biosynthetic process (GO:0006188) | 3.43842187 |
| 73 | * signal transduction in response to DNA damage (GO:0042770) | 3.43518488 |
| 74 | mitotic recombination (GO:0006312) | 3.42843265 |
| 75 | * positive regulation of cell cycle arrest (GO:0071158) | 3.39214487 |
| 76 | viral transcription (GO:0019083) | 3.39072553 |
| 77 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.38305166 |
| 78 | translational termination (GO:0006415) | 3.37645947 |
| 79 | * regulation of cell cycle arrest (GO:0071156) | 3.37594614 |
| 80 | spliceosomal complex assembly (GO:0000245) | 3.35546582 |
| 81 | chromatin remodeling at centromere (GO:0031055) | 3.35354781 |
| 82 | rRNA metabolic process (GO:0016072) | 3.34690000 |
| 83 | telomere maintenance via telomere lengthening (GO:0010833) | 3.34206672 |
| 84 | translation (GO:0006412) | 3.34088343 |
| 85 | establishment of integrated proviral latency (GO:0075713) | 3.33228047 |
| 86 | cellular component biogenesis (GO:0044085) | 3.32406384 |
| 87 | translational initiation (GO:0006413) | 3.31017863 |
| 88 | * negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 3.30770960 |
| 89 | * negative regulation of cell cycle G1/S phase transition (GO:1902807) | 3.30770960 |
| 90 | regulation of mitochondrial translation (GO:0070129) | 3.30674967 |
| 91 | tRNA aminoacylation for protein translation (GO:0006418) | 3.30547206 |
| 92 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.28502036 |
| 93 | protein localization to mitochondrion (GO:0070585) | 3.28483236 |
| 94 | DNA unwinding involved in DNA replication (GO:0006268) | 3.26517957 |
| 95 | mitotic metaphase plate congression (GO:0007080) | 3.26219210 |
| 96 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.25061774 |
| 97 | tRNA aminoacylation (GO:0043039) | 3.24894094 |
| 98 | amino acid activation (GO:0043038) | 3.24894094 |
| 99 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.23719244 |
| 100 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.23719244 |
| 101 | translational elongation (GO:0006414) | 3.21360464 |
| 102 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.21004926 |
| 103 | DNA damage response, detection of DNA damage (GO:0042769) | 3.20869548 |
| 104 | * regulation of cellular amine metabolic process (GO:0033238) | 3.20289030 |
| 105 | protein neddylation (GO:0045116) | 3.19898178 |
| 106 | transcription from RNA polymerase I promoter (GO:0006360) | 3.18576480 |
| 107 | termination of RNA polymerase I transcription (GO:0006363) | 3.16380930 |
| 108 | peptidyl-histidine modification (GO:0018202) | 3.15588986 |
| 109 | mitotic sister chromatid segregation (GO:0000070) | 3.14040686 |
| 110 | establishment of protein localization to mitochondrion (GO:0072655) | 3.13507999 |
| 111 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.12656430 |
| 112 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.10728943 |
| 113 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.10728943 |
| 114 | maturation of 5.8S rRNA (GO:0000460) | 3.09278133 |
| 115 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.07432507 |
| 116 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.06396391 |
| 117 | metaphase plate congression (GO:0051310) | 3.06021618 |
| 118 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.05711453 |
| 119 | * positive regulation of protein ubiquitination (GO:0031398) | 3.05146900 |
| 120 | de novo protein folding (GO:0006458) | 3.04446038 |
| 121 | protein targeting to mitochondrion (GO:0006626) | 3.04113466 |
| 122 | respiratory electron transport chain (GO:0022904) | 3.03798564 |
| 123 | oxidative phosphorylation (GO:0006119) | 3.03704142 |
| 124 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.02703963 |
| 125 | inner mitochondrial membrane organization (GO:0007007) | 2.96758994 |
| 126 | de novo posttranslational protein folding (GO:0051084) | 2.95740501 |
| 127 | electron transport chain (GO:0022900) | 2.94672737 |
| 128 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.89918851 |
| 129 | * positive regulation of protein modification by small protein conjugation or removal (GO:1903322) | 2.89753574 |
| 130 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.88883043 |
| 131 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.88021240 |
| 132 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83151256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.07351667 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.44800160 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.41498155 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.02519232 |
| 5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.96671349 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.90023238 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.89268371 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.59930973 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.53092364 |
| 10 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.30697690 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.23453199 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.20228117 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.02375170 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 3.01346086 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.93596109 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.91613704 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.80936272 |
| 18 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.57778710 |
| 19 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.53885413 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.48525043 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.47149322 |
| 22 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.46612031 |
| 23 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.46169822 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.45200351 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.43426633 |
| 26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.43090513 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42990489 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.35132876 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19829318 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.18573117 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.17357746 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.14746202 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.11142539 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.02853256 |
| 35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95830316 |
| 36 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.95183034 |
| 37 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.92599140 |
| 38 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.90780614 |
| 39 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.86267117 |
| 40 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.85013910 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.83451741 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79693127 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.78755877 |
| 44 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76011335 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.75426880 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.69135373 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59059869 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58498290 |
| 49 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50477580 |
| 50 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48317708 |
| 51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46449135 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.44301365 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43982191 |
| 54 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40677087 |
| 55 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.39648925 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39334444 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39257234 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33984214 |
| 59 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.31020952 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29432621 |
| 61 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24746984 |
| 62 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.23430997 |
| 63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23200548 |
| 64 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19314088 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18248253 |
| 66 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.16990696 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15009091 |
| 68 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.14589388 |
| 69 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11785470 |
| 70 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.11351927 |
| 71 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11109923 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.07961006 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07629514 |
| 74 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06832494 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04890556 |
| 76 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.04460404 |
| 77 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04166851 |
| 78 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03732241 |
| 79 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03346784 |
| 80 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99460355 |
| 81 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99332785 |
| 82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98854921 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.98028188 |
| 84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97709336 |
| 85 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97019789 |
| 86 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96415299 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95558514 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95542266 |
| 89 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.94144876 |
| 90 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.93663444 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93208632 |
| 92 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92152699 |
| 93 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.91798184 |
| 94 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90698287 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90664759 |
| 96 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90603651 |
| 97 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89949724 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89530588 |
| 99 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88826765 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88656329 |
| 101 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.87594514 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86622579 |
| 103 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85381533 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85166998 |
| 105 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.84954241 |
| 106 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.83440587 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83016791 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.80661928 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79274992 |
| 110 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.77169574 |
| 111 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76737665 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75953918 |
| 113 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.75112993 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.74887659 |
| 115 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.74767541 |
| 116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73688363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.94020280 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.91297863 |
| 3 | MP0010094_abnormal_chromosome_stability | 4.37837011 |
| 4 | MP0003111_abnormal_nucleus_morphology | 4.37734582 |
| 5 | MP0003077_abnormal_cell_cycle | 4.01145308 |
| 6 | MP0008058_abnormal_DNA_repair | 3.79117229 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.54515764 |
| 8 | MP0008057_abnormal_DNA_replication | 3.30593997 |
| 9 | MP0008932_abnormal_embryonic_tissue | 3.20246564 |
| 10 | MP0008007_abnormal_cellular_replicative | 3.02598455 |
| 11 | MP0003718_maternal_effect | 2.94447386 |
| 12 | MP0003123_paternal_imprinting | 2.60244205 |
| 13 | MP0003786_premature_aging | 2.46796888 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.30094111 |
| 15 | * MP0001730_embryonic_growth_arrest | 2.15768814 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.06554646 |
| 17 | MP0003186_abnormal_redox_activity | 2.06222031 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.01688967 |
| 19 | MP0000350_abnormal_cell_proliferation | 1.95139506 |
| 20 | MP0006035_abnormal_mitochondrial_morpho | 1.85283485 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.81287496 |
| 22 | MP0001529_abnormal_vocalization | 1.79223724 |
| 23 | MP0003315_abnormal_perineum_morphology | 1.74843710 |
| 24 | MP0000749_muscle_degeneration | 1.72428375 |
| 25 | MP0008260_abnormal_autophagy | 1.59426512 |
| 26 | MP0001697_abnormal_embryo_size | 1.50126746 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.49686467 |
| 28 | MP0004233_abnormal_muscle_weight | 1.48608849 |
| 29 | MP0002160_abnormal_reproductive_system | 1.47831000 |
| 30 | * MP0002080_prenatal_lethality | 1.46468747 |
| 31 | MP0004133_heterotaxia | 1.44115686 |
| 32 | MP0001672_abnormal_embryogenesis/_devel | 1.37782312 |
| 33 | MP0005380_embryogenesis_phenotype | 1.37782312 |
| 34 | MP0000313_abnormal_cell_death | 1.37012944 |
| 35 | MP0005501_abnormal_skin_physiology | 1.35813238 |
| 36 | MP0003121_genomic_imprinting | 1.35310996 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.34290565 |
| 38 | MP0000358_abnormal_cell_content/ | 1.33405981 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.31703109 |
| 40 | MP0003984_embryonic_growth_retardation | 1.23830445 |
| 41 | MP0001661_extended_life_span | 1.22677002 |
| 42 | MP0010030_abnormal_orbit_morphology | 1.21708920 |
| 43 | MP0002088_abnormal_embryonic_growth/wei | 1.19774421 |
| 44 | MP0001764_abnormal_homeostasis | 1.19428629 |
| 45 | MP0005499_abnormal_olfactory_system | 1.18996858 |
| 46 | MP0005394_taste/olfaction_phenotype | 1.18996858 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.17413285 |
| 48 | MP0009697_abnormal_copulation | 1.16808287 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16786100 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.16561401 |
| 51 | MP0002085_abnormal_embryonic_tissue | 1.15707852 |
| 52 | MP0004147_increased_porphyrin_level | 1.15166776 |
| 53 | MP0002132_abnormal_respiratory_system | 1.10351162 |
| 54 | MP0000372_irregular_coat_pigmentation | 1.09738952 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.08790813 |
| 56 | MP0001905_abnormal_dopamine_level | 1.07288088 |
| 57 | MP0005389_reproductive_system_phenotype | 1.07164017 |
| 58 | MP0002751_abnormal_autonomic_nervous | 1.04577170 |
| 59 | MP0000490_abnormal_crypts_of | 1.04240741 |
| 60 | MP0003890_abnormal_embryonic-extraembry | 1.03806209 |
| 61 | MP0002269_muscular_atrophy | 1.01710178 |
| 62 | MP0000678_abnormal_parathyroid_gland | 1.00694325 |
| 63 | MP0005266_abnormal_metabolism | 0.98610588 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97672213 |
| 65 | MP0002796_impaired_skin_barrier | 0.96814379 |
| 66 | MP0002163_abnormal_gland_morphology | 0.92404384 |
| 67 | MP0002210_abnormal_sex_determination | 0.91573033 |
| 68 | MP0002102_abnormal_ear_morphology | 0.90459275 |
| 69 | MP0001542_abnormal_bone_strength | 0.89773244 |
| 70 | MP0002084_abnormal_developmental_patter | 0.88105123 |
| 71 | MP0002736_abnormal_nociception_after | 0.87197053 |
| 72 | MP0000647_abnormal_sebaceous_gland | 0.86443606 |
| 73 | MP0002938_white_spotting | 0.83458465 |
| 74 | MP0000566_synostosis | 0.82511226 |
| 75 | MP0005330_cardiomyopathy | 0.81856022 |
| 76 | MP0001145_abnormal_male_reproductive | 0.81428990 |
| 77 | MP0001881_abnormal_mammary_gland | 0.79910770 |
| 78 | MP0005332_abnormal_amino_acid | 0.77938835 |
| 79 | MP0002653_abnormal_ependyma_morphology | 0.77273814 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 0.76412805 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 0.76396448 |
| 82 | MP0004084_abnormal_cardiac_muscle | 0.76247783 |
| 83 | MP0000747_muscle_weakness | 0.75346550 |
| 84 | MP0002111_abnormal_tail_morphology | 0.75227056 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 0.74602288 |
| 86 | MP0003119_abnormal_digestive_system | 0.74231634 |
| 87 | MP0000627_abnormal_mammary_gland | 0.73673787 |
| 88 | MP0005384_cellular_phenotype | 0.73507064 |
| 89 | MP0001293_anophthalmia | 0.73284874 |
| 90 | MP0005408_hypopigmentation | 0.72926514 |
| 91 | MP0005451_abnormal_body_composition | 0.71015208 |
| 92 | MP0010307_abnormal_tumor_latency | 0.70843882 |
| 93 | MP0005395_other_phenotype | 0.69337535 |
| 94 | MP0002722_abnormal_immune_system | 0.69201617 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.69106833 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.68905340 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.68779849 |
| 98 | MP0008873_increased_physiological_sensi | 0.68659652 |
| 99 | MP0000537_abnormal_urethra_morphology | 0.67087978 |
| 100 | MP0003937_abnormal_limbs/digits/tail_de | 0.64929528 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.64197919 |
| 102 | MP0001919_abnormal_reproductive_system | 0.63973712 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.63828522 |
| 104 | MP0000653_abnormal_sex_gland | 0.63745184 |
| 105 | MP0001853_heart_inflammation | 0.63365980 |
| 106 | MP0002822_catalepsy | 0.63058105 |
| 107 | MP0003122_maternal_imprinting | 0.62846589 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.62751885 |
| 109 | MP0001216_abnormal_epidermal_layer | 0.62531721 |
| 110 | * MP0001727_abnormal_embryo_implantation | 0.62156986 |
| 111 | MP0001929_abnormal_gametogenesis | 0.60903395 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.60364557 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.59892381 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.59267487 |
| 115 | MP0000049_abnormal_middle_ear | 0.59174482 |
| 116 | MP0001119_abnormal_female_reproductive | 0.58315135 |
| 117 | MP0001188_hyperpigmentation | 0.57800945 |
| 118 | MP0002098_abnormal_vibrissa_morphology | 0.57687803 |
| 119 | MP0002177_abnormal_outer_ear | 0.56620757 |
| 120 | MP0000703_abnormal_thymus_morphology | 0.56530272 |
| 121 | MP0003646_muscle_fatigue | 0.56407330 |
| 122 | MP0000858_altered_metastatic_potential | 0.55436186 |
| 123 | MP0001849_ear_inflammation | 0.55397641 |
| 124 | MP0001243_abnormal_dermal_layer | 0.55296862 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.55244273 |
| 126 | MP0002429_abnormal_blood_cell | 0.54768901 |
| 127 | MP0002398_abnormal_bone_marrow | 0.54282481 |
| 128 | MP0000751_myopathy | 0.54210747 |
| 129 | MP0001286_abnormal_eye_development | 0.54148116 |
| 130 | MP0009672_abnormal_birth_weight | 0.53664406 |
| 131 | MP0003763_abnormal_thymus_physiology | 0.53517166 |
| 132 | MP0005670_abnormal_white_adipose | 0.53256609 |
| 133 | MP0010771_integument_phenotype | 0.53251619 |
| 134 | MP0003941_abnormal_skin_development | 0.52549393 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.51103198 |
| 136 | MP0002090_abnormal_vision | 0.51072965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.75977127 |
| 2 | Abnormality of glycolysis (HP:0004366) | 4.70181892 |
| 3 | Increased serum pyruvate (HP:0003542) | 4.70181892 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.57001050 |
| 5 | Cerebral hypomyelination (HP:0006808) | 4.50620995 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.22506298 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.20428864 |
| 8 | Mitochondrial inheritance (HP:0001427) | 4.14689327 |
| 9 | Increased CSF lactate (HP:0002490) | 4.00789441 |
| 10 | Breast hypoplasia (HP:0003187) | 3.81993045 |
| 11 | Hepatic necrosis (HP:0002605) | 3.74024624 |
| 12 | Acute encephalopathy (HP:0006846) | 3.67240971 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.63050837 |
| 14 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.55786422 |
| 15 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.55786422 |
| 16 | Increased serum lactate (HP:0002151) | 3.47479644 |
| 17 | Rough bone trabeculation (HP:0100670) | 3.46414335 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.45593864 |
| 19 | Carpal bone hypoplasia (HP:0001498) | 3.43322800 |
| 20 | Abnormal number of erythroid precursors (HP:0012131) | 3.42657830 |
| 21 | Reticulocytopenia (HP:0001896) | 3.41768098 |
| 22 | Oral leukoplakia (HP:0002745) | 3.40827069 |
| 23 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.32773132 |
| 24 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.32773132 |
| 25 | Abnormal protein glycosylation (HP:0012346) | 3.32773132 |
| 26 | Abnormal glycosylation (HP:0012345) | 3.32773132 |
| 27 | Aplastic anemia (HP:0001915) | 3.08080611 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.06854883 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 3.06320908 |
| 30 | Cholecystitis (HP:0001082) | 3.05344488 |
| 31 | Abnormal gallbladder physiology (HP:0012438) | 3.05344488 |
| 32 | Degeneration of anterior horn cells (HP:0002398) | 3.02716852 |
| 33 | Abnormality of the anterior horn cell (HP:0006802) | 3.02716852 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01698252 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91501664 |
| 36 | Exercise intolerance (HP:0003546) | 2.88140079 |
| 37 | Hypokinesia (HP:0002375) | 2.88084266 |
| 38 | Macrocytic anemia (HP:0001972) | 2.86491809 |
| 39 | Patellar aplasia (HP:0006443) | 2.81509707 |
| 40 | Lactic acidosis (HP:0003128) | 2.78564543 |
| 41 | Respiratory failure (HP:0002878) | 2.74285266 |
| 42 | Lipid accumulation in hepatocytes (HP:0006561) | 2.70890459 |
| 43 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.68817610 |
| 44 | Microvesicular hepatic steatosis (HP:0001414) | 2.68741271 |
| 45 | Colon cancer (HP:0003003) | 2.68515979 |
| 46 | Type I transferrin isoform profile (HP:0003642) | 2.67177774 |
| 47 | Emotional lability (HP:0000712) | 2.60553876 |
| 48 | Cerebral edema (HP:0002181) | 2.60396863 |
| 49 | Multiple enchondromatosis (HP:0005701) | 2.59606187 |
| 50 | CNS demyelination (HP:0007305) | 2.56447876 |
| 51 | Ependymoma (HP:0002888) | 2.55679428 |
| 52 | Abnormal trabecular bone morphology (HP:0100671) | 2.55200147 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.52834015 |
| 54 | CNS hypomyelination (HP:0003429) | 2.52325893 |
| 55 | Microretrognathia (HP:0000308) | 2.51519999 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.50833534 |
| 57 | Secondary amenorrhea (HP:0000869) | 2.50072771 |
| 58 | Testicular atrophy (HP:0000029) | 2.47757655 |
| 59 | Postnatal microcephaly (HP:0005484) | 2.47639290 |
| 60 | Methylmalonic aciduria (HP:0012120) | 2.46800740 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.44083220 |
| 62 | Trismus (HP:0000211) | 2.43718246 |
| 63 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.39363188 |
| 64 | Agnosia (HP:0010524) | 2.39101124 |
| 65 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.38757308 |
| 66 | Selective tooth agenesis (HP:0001592) | 2.36757806 |
| 67 | Facial cleft (HP:0002006) | 2.36277469 |
| 68 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.35441480 |
| 69 | Irregular epiphyses (HP:0010582) | 2.35437834 |
| 70 | Exertional dyspnea (HP:0002875) | 2.30805768 |
| 71 | Premature ovarian failure (HP:0008209) | 2.29610500 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.26229837 |
| 73 | Pallor (HP:0000980) | 2.23855442 |
| 74 | Renal Fanconi syndrome (HP:0001994) | 2.22372638 |
| 75 | Unsteady gait (HP:0002317) | 2.22139987 |
| 76 | Leukodystrophy (HP:0002415) | 2.20871743 |
| 77 | Absent radius (HP:0003974) | 2.20756987 |
| 78 | Meckel diverticulum (HP:0002245) | 2.20719461 |
| 79 | Respiratory difficulties (HP:0002880) | 2.20312804 |
| 80 | Poor head control (HP:0002421) | 2.19981699 |
| 81 | Premature graying of hair (HP:0002216) | 2.19494871 |
| 82 | Abnormality of the preputium (HP:0100587) | 2.19346260 |
| 83 | Chromsome breakage (HP:0040012) | 2.17502934 |
| 84 | Megaloblastic anemia (HP:0001889) | 2.17009175 |
| 85 | Absent thumb (HP:0009777) | 2.14101567 |
| 86 | Pancytopenia (HP:0001876) | 2.12527692 |
| 87 | Abnormality of the ileum (HP:0001549) | 2.11995864 |
| 88 | Abnormality of the labia minora (HP:0012880) | 2.11470724 |
| 89 | Bone marrow hypocellularity (HP:0005528) | 2.11276793 |
| 90 | Hypoplastic pelvis (HP:0008839) | 2.11176074 |
| 91 | Cellular immunodeficiency (HP:0005374) | 2.10579299 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08295611 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 2.08295611 |
| 94 | Hyperalaninemia (HP:0003348) | 2.08295611 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06678708 |
| 96 | 11 pairs of ribs (HP:0000878) | 2.05727639 |
| 97 | Large for gestational age (HP:0001520) | 2.05636283 |
| 98 | Delusions (HP:0000746) | 2.05127005 |
| 99 | Horseshoe kidney (HP:0000085) | 2.02904237 |
| 100 | Aplasia involving forearm bones (HP:0009822) | 2.02491407 |
| 101 | Absent forearm bone (HP:0003953) | 2.02491407 |
| 102 | Upper limb muscle weakness (HP:0003484) | 2.01471038 |
| 103 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.00001860 |
| 104 | Neoplasm of the adrenal gland (HP:0100631) | 1.99301066 |
| 105 | Glossoptosis (HP:0000162) | 1.99019756 |
| 106 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.98291370 |
| 107 | Absent epiphyses (HP:0010577) | 1.98291370 |
| 108 | Progressive muscle weakness (HP:0003323) | 1.97546537 |
| 109 | Optic disc pallor (HP:0000543) | 1.95814552 |
| 110 | Medulloblastoma (HP:0002885) | 1.95690459 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 1.94314573 |
| 112 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93625442 |
| 113 | Generalized aminoaciduria (HP:0002909) | 1.93473226 |
| 114 | Sparse eyelashes (HP:0000653) | 1.93406526 |
| 115 | Impulsivity (HP:0100710) | 1.93108375 |
| 116 | Opisthotonus (HP:0002179) | 1.92746396 |
| 117 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.91738387 |
| 118 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.90431009 |
| 119 | Neoplasm of the pancreas (HP:0002894) | 1.89364080 |
| 120 | Muscle fiber atrophy (HP:0100295) | 1.86662557 |
| 121 | Lethargy (HP:0001254) | 1.86428879 |
| 122 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.85882593 |
| 123 | Stenosis of the external auditory canal (HP:0000402) | 1.85733827 |
| 124 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85660144 |
| 125 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.84952602 |
| 126 | Triphalangeal thumb (HP:0001199) | 1.84505685 |
| 127 | Abnormality of placental membranes (HP:0011409) | 1.83580088 |
| 128 | Amniotic constriction ring (HP:0009775) | 1.83580088 |
| 129 | Abnormal number of incisors (HP:0011064) | 1.83307220 |
| 130 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.83022073 |
| 131 | Abnormality of the umbilical cord (HP:0010881) | 1.82327544 |
| 132 | Abnormal lung lobation (HP:0002101) | 1.80308522 |
| 133 | Cleft eyelid (HP:0000625) | 1.80204300 |
| 134 | Shoulder girdle muscle weakness (HP:0003547) | 1.76407599 |
| 135 | Death in infancy (HP:0001522) | 1.75861574 |
| 136 | Abnormality of the astrocytes (HP:0100707) | 1.69026282 |
| 137 | Astrocytoma (HP:0009592) | 1.69026282 |
| 138 | Late onset (HP:0003584) | 1.68063746 |
| 139 | Dicarboxylic aciduria (HP:0003215) | 1.67637405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.95050578 |
| 2 | WEE1 | 4.11353060 |
| 3 | VRK2 | 3.90419217 |
| 4 | STK16 | 3.73775660 |
| 5 | EIF2AK1 | 3.70312254 |
| 6 | TRIB3 | 3.34937379 |
| 7 | TSSK6 | 3.29520624 |
| 8 | SRPK1 | 2.65084767 |
| 9 | PLK4 | 2.50652772 |
| 10 | CDC7 | 2.42815508 |
| 11 | NME2 | 2.38284236 |
| 12 | EIF2AK3 | 2.38090645 |
| 13 | NEK1 | 2.23561608 |
| 14 | VRK1 | 2.03389507 |
| 15 | TESK2 | 1.99594461 |
| 16 | TRIM28 | 1.82935462 |
| 17 | NME1 | 1.82778551 |
| 18 | EPHA2 | 1.72905014 |
| 19 | PLK3 | 1.72214603 |
| 20 | CCNB1 | 1.70057355 |
| 21 | PLK1 | 1.60698538 |
| 22 | PIM2 | 1.59847839 |
| 23 | TTK | 1.48056754 |
| 24 | BRSK2 | 1.47549230 |
| 25 | PBK | 1.47057971 |
| 26 | ACVR1B | 1.44163117 |
| 27 | AURKA | 1.42197962 |
| 28 | MKNK1 | 1.41524184 |
| 29 | ZAK | 1.39315897 |
| 30 | NEK2 | 1.32641104 |
| 31 | TLK1 | 1.32135896 |
| 32 | BRAF | 1.28971562 |
| 33 | ARAF | 1.28959338 |
| 34 | RPS6KB2 | 1.24433797 |
| 35 | CDK9 | 1.24386473 |
| 36 | AURKB | 1.23356243 |
| 37 | KDR | 1.23116747 |
| 38 | PASK | 1.21922553 |
| 39 | SMG1 | 1.21718410 |
| 40 | BRSK1 | 1.19580421 |
| 41 | TESK1 | 1.12555210 |
| 42 | MAP3K12 | 1.06676485 |
| 43 | DYRK3 | 1.05108233 |
| 44 | ATR | 1.04575839 |
| 45 | CDK7 | 0.99880845 |
| 46 | PNCK | 0.99655558 |
| 47 | CSNK1A1L | 0.97943483 |
| 48 | AKT3 | 0.96761031 |
| 49 | TAF1 | 0.95980588 |
| 50 | LIMK1 | 0.94280884 |
| 51 | PAK4 | 0.94249354 |
| 52 | CHEK2 | 0.93397179 |
| 53 | MST1R | 0.92866926 |
| 54 | NUAK1 | 0.92171351 |
| 55 | DYRK2 | 0.89964627 |
| 56 | MAP3K8 | 0.88717712 |
| 57 | DAPK1 | 0.88265509 |
| 58 | MST4 | 0.86847441 |
| 59 | BCKDK | 0.86668224 |
| 60 | BCR | 0.85759488 |
| 61 | CSNK1G1 | 0.85225744 |
| 62 | MYLK | 0.83098784 |
| 63 | EIF2AK2 | 0.81600696 |
| 64 | PRKCI | 0.80168285 |
| 65 | MAP3K11 | 0.80133691 |
| 66 | MAPKAPK5 | 0.80087002 |
| 67 | CSNK2A1 | 0.79766252 |
| 68 | SCYL2 | 0.72456673 |
| 69 | CSNK2A2 | 0.72404420 |
| 70 | CSNK1G2 | 0.72396296 |
| 71 | STK38L | 0.71363762 |
| 72 | PAK1 | 0.70835153 |
| 73 | RPS6KA4 | 0.69843069 |
| 74 | PLK2 | 0.69775528 |
| 75 | STK10 | 0.69408230 |
| 76 | CHEK1 | 0.69255671 |
| 77 | MKNK2 | 0.67055202 |
| 78 | CDK8 | 0.61669996 |
| 79 | TAOK2 | 0.60294778 |
| 80 | PDK3 | 0.54624113 |
| 81 | PDK4 | 0.54624113 |
| 82 | CASK | 0.54013238 |
| 83 | TGFBR1 | 0.52426481 |
| 84 | MAP2K7 | 0.52420694 |
| 85 | MET | 0.50894324 |
| 86 | ABL2 | 0.50612804 |
| 87 | STK4 | 0.50455286 |
| 88 | MAPKAPK3 | 0.50440372 |
| 89 | OBSCN | 0.50187095 |
| 90 | ERBB4 | 0.49690926 |
| 91 | MAP4K2 | 0.49335974 |
| 92 | CDK4 | 0.49014776 |
| 93 | CSNK1G3 | 0.48209723 |
| 94 | SIK3 | 0.47733840 |
| 95 | MAP3K3 | 0.47220991 |
| 96 | PDK2 | 0.46982197 |
| 97 | ILK | 0.45560233 |
| 98 | LMTK2 | 0.44880469 |
| 99 | CDK19 | 0.44498729 |
| 100 | RPS6KA5 | 0.43475630 |
| 101 | YES1 | 0.43148635 |
| 102 | CDK2 | 0.42438584 |
| 103 | PIM1 | 0.42254201 |
| 104 | CAMK2G | 0.38570902 |
| 105 | BLK | 0.38126356 |
| 106 | IRAK3 | 0.37958340 |
| 107 | DAPK3 | 0.36358713 |
| 108 | ERBB3 | 0.35901940 |
| 109 | CDK1 | 0.34886953 |
| 110 | ATM | 0.31908240 |
| 111 | ALK | 0.31751705 |
| 112 | WNK3 | 0.29900519 |
| 113 | PTK2 | 0.29859618 |
| 114 | FLT3 | 0.29598530 |
| 115 | AKT2 | 0.27856775 |
| 116 | CLK1 | 0.27086025 |
| 117 | CDK18 | 0.25868717 |
| 118 | GRK6 | 0.25570654 |
| 119 | MAP2K6 | 0.25377070 |
| 120 | CDK14 | 0.25260490 |
| 121 | CSNK1E | 0.25134403 |
| 122 | ZAP70 | 0.24911945 |
| 123 | PAK6 | 0.24223375 |
| 124 | CDK15 | 0.24090363 |
| 125 | ADRBK2 | 0.24089573 |
| 126 | CDK11A | 0.24016379 |
| 127 | MAP2K3 | 0.23933796 |
| 128 | IRAK4 | 0.23878820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 5.44119296 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.07306286 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.81356367 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.68207136 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.64712338 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.28653748 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.95425725 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.68126257 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.59012400 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.53880772 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.52363089 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.49979153 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.49437468 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.43238969 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.23101153 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.01206061 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.84675848 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.77040979 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.70481193 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61612367 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.59277084 |
| 22 | Purine metabolism_Homo sapiens_hsa00230 | 1.53225276 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52415156 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.49852572 |
| 25 | RNA degradation_Homo sapiens_hsa03018 | 1.45160447 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.38089812 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35425158 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31649772 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28132711 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23561284 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22870215 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17601230 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16536812 |
| 34 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16104541 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14339756 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13225307 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12868753 |
| 38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.10888366 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04376094 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00929482 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98621263 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.90672179 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87660350 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87659694 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85146024 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83559602 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83017661 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.79066185 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76259946 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75728452 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71491978 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71034495 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70683030 |
| 54 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69946319 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68931624 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65139485 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63675709 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60526666 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58570405 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57630233 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57437396 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53437667 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50407363 |
| 64 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.49341928 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46703454 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43782557 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43005302 |
| 68 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42696671 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41740039 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.41276459 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40557414 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39638361 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38589687 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33266053 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33174263 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32726217 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32085054 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29061875 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28518734 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28274590 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27295969 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27122098 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24772159 |
| 84 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24555562 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24402277 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23871547 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18955007 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.17585272 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.16153405 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.15722632 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14563716 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14264556 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13070721 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12939421 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.11809972 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.10587137 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.10345554 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.07931124 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06999425 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.06042746 |
| 101 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.06019060 |
| 102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.05800533 |
| 103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.05352062 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.04723943 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.03629314 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.03224114 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.02710869 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.02265552 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02178908 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.01855683 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.01792123 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.01555755 |
| 113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.00520491 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0159929 |
| 115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | -0.0045374 |

